Orexin Receptor Antagonism for the Treatment of Alcohol Use Disorder and Stress-Related Drinking

NCT07214207 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

250

Enrollment

OTHER

Sponsor class

Conditions

Alcohol Use Disorder

Interventions

DRUG: Suvorexant 10 mg
OTHER: Placebo

Sponsor

Ohio State University

Collaborators

[object Object]